Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

DEF 14A

SEC Filing Details

Document Details

Filing Date
May 1, 2017
Document Date
Jun 18, 2017
Form Description

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Filing Group
Proxy Filings
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC


Copyright 2017 - Stemline Therapeutics, Inc. All rights reserved